Alembic Limited Company Profile
At Alembic, we recognize that Research and Development is vital for our survival and growth as a leading pharmaceutical firm in India. Research and Development at Alembic is focussed on fermentation technology, strain improvement, industrial enzymes, non-infringing process developments for API & intermediates, development of innovative formulations, NDDS. The Department of Scientific and Industrial Research (DSIR) of the Government of India recognize Alembic's Research and Development Unit since 1975. Research and Development efforts at Alembic are focused on 3 broad categories Chemistry and Synthesis Formulations Development Contract / Collaborated Research
Location
Alembic Road
Vadodara
Gujarat
390003
India
Contact
Phone: +91-265-3007-652
Fax: +91-265-2281-508
Email: bp.saradhi@alembic.co.in
News Articles
Accu-Break and Alembic join in tablet-splitting tech accord
Tablet technology firm Accu-Break Pharmaceuticals has signed a product development and licensing agreement with Indian generic drugmaker Alembic Pharmaceuticals.
Alembic shoots up on Pristiq generic approval and Ranbaxy tie
Shares of Alembic Pharmaceuticals rose 15% on Indian bourses after the company said that it had received US FDA approval for its NDA for desvenlafaxine base extended release tablets, a bioequivalent v...
Pfizer sues Alembic, Zydus (and Watson) over US Pristiq ANDAs
Pfizer has sued a clutch of Indian firms in a suit concerning their US abbreviated new drug applications (ANDAs) for its antidepressant Pristiq (desvenlafaxine succinate). Alembic Pharmaceuticals in...
Alembic-Accu-Break alliance targets dosage convenience
India's Alembic Pharmaceuticals and Accu-Break Pharmaceuticals have entered into a development and licence pact to develop new branded products based on the US firm's Accu-Break tablet technologies....
Ranbaxy in deal with Alembic to market bioequivalent Pristiq in USA
The US subsidiary of India's largest drugmaker, Ranbaxy Laboratories (AB: BO), which is majority owned by Japan's Daiichi Sankyo (TYO: 4568 ), has entered into an in-licensing agreement with Indian fi...
BOCA RATON, Fla., June 27, 2012 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announced today that Breckenridge and Alembic Pharmaceuticals Limited were named codefendants in a Paragraph IV l...
Accu-Break, Alembic enter into product development and license agreement
India-based Accu-Break Pharmaceuticals (ABP) has entered into a development and license agreement with Alembic Pharmaceuticals of Plantation, Fla., to develop new brand products that will use ABP’s...
BOCA RATON, Fla., June 14, 2012 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announced today that Breckenridge and Alembic Pharmaceuticals Limited have settled their Paragraph IV patent liti...
Drugs and Medications
Lithium carbonate capsules usp [Alembic Limited]
Lithium Carbonate Capsules USP
Meprobamate [Heritage Pharmaceuticals Inc]
Meprobamate Tablets USP
PubMed Articles
Pear distillates are generally produced from the Bartlett variety because of its rich aroma. In this study, a chemical and sensorial comparative examination of pear distillates from the three main var...
Clinical Trials
None
Companies
At Alembic, we recognize that Research and Development is vital for our survival and growth as a leading pharmaceutical firm in India. Research and Development at Alembic is focussed on fermentation t...
More Information about "Alembic Limited" on BioPortfolio
We have published hundreds of Alembic Limited news stories on BioPortfolio along with dozens of Alembic Limited Clinical Trials and PubMed Articles about Alembic Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alembic Limited Companies in our database. You can also find out about relevant Alembic Limited Drugs and Medications on this site too.
